Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07501000 · ClinicalTrials.gov registry record · NA
Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen
A NA study, sponsored by Revision Skincare.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT07501000 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 11 participants.
The verdict
NCT07501000, a NA study, has completed, sponsored by Revision Skincare.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
A12-week single-center, open-label, clinical study is being conducted to assess the efficacy and tolerability of the Brightening Treatment paired with a skincare regimen on healthy female subjects aged 20-65 years with Fitzpatrick Skin Types I - VI and moderate global facial pigmentation due to sun exposure, blemishes, and/or procedures when applied by a clinician in a series of 4 sessions at 2-week intervals. The procedure in this clinical study will include the brightening treatment, retinol serum, and a post-procedure cream. The study visits include baseline, week 2, 6, and 12.
Interventions
- OTHER Brightening Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2025-01-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07501000
The ClinicalTrials.gov registry entry for NCT07501000 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brightening Treatment is the first listed.
NCT07501000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07501000 about?
NCT07501000 is a clinical study titled "Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen". A12-week single-center, open-label, clinical study is being conducted to assess the efficacy and tolerability of the Brightening Treatment paired with a skincare regimen on healthy female subjects aged 20-65 years with Fitzpatrick Skin Types I - VI and moderate global facial pigmentation due to sun ...
What is the current status of trial NCT07501000?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2024-10-07. Estimated completion is 2025-01-23.
What interventions are being tested in trial NCT07501000?
The interventions under investigation include: Brightening Treatment (OTHER).
Who is sponsoring clinical trial NCT07501000?
This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.